• 1
    Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983; 32: 9439.
  • 2
    Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352: 2139.
  • 3
    Parving H-H, Østerby R, Ritz E. Diabetic nephropathy. In: BrennerBM, LevineS, eds. The Kidney. Philadelphia: W.B. Saunders Company, 2000; 173173.
  • 4
    Porte D Jr, Schwartz MW. Diabetes complications: why is glucose potentially toxic? Science 1996; 272: 699700.
  • 5
    Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving H-H. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 1994; 17: 124751.
  • 6
    Florey CV, Uppal S, Lowy C. Relation between blood pressure, weight, and plasma sugar and serum insulin levels in schoolchildren aged 9–12 years in Westland, Holland. BMJ 1976; 1: 136871.
  • 7
    Jarrett RJ, Keen H, McCartney M, Fuller JH, Hamilton PJ, Reid DD et al. Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension. Int J Epidemiol 1978; 7: 1524.
  • 8
    Mathiesen ER, Hilsted J, Feldt-Rasmussen B, Bonde-Petersen F, Christensen NJ, Parving H-H. The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients. Diabetes 1985; 34: 13015.
  • 9
    O'Hara JA, Ferriss JB, Twomey BM, Gonggrijp H, O'Sullivan DJ. Changes in blood pressure, body fluids, circulating angiotensin II and aldosterone, with improved diabetic control. Clinical Science 1982; 63: 415s8s.
  • 10
    Parving H-H, Noer I, Deckert T, Evrin P-E, Nielsen SL, Lyngsøe J et al. The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 1976; 12: 1616.
  • 11
    Marfella R, Nappo F, De Angelis L, Paolisso G, Tagliamonte MR, Giugliano D. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care 2000; 23: 65863.
  • 12
    Harrison MH. Effects on thermal stress and exercise on blood volume in humans. Physiol Rev 1985; 65: 149209.
  • 13
    Emmeluth C, Drummer C, Gerzer R, Bie P. Natriuresis in conscious dogs caused by increased carotid [Na+] during angiotensin II and aldosterone blockade. Acta Physiol Scand 1994; 151: 40311.
  • 14
    Bie P, Sandgaard NC. Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1R10.
  • 15
    Andersen LJ, Andersen JL, Pump B, Bie P. Natriuresis induced by mild hypernatremia in humans. Am J Physiol Regul Integr Comp Physiol 2002; 282: R175461.
  • 16
    Mehlsen J, Wiinberg N, Bang LE, Bentzon MW, Nielsen PE, Jensen H. Guidelines for ambulatory blood pressure measuring. Ugeskrift for laeger 1999; Suppl 8.
  • 17
    Altman D. Clinical trials. In: AltmanG, ed. Practical Statistics for Medical Research. London: Chapman & Hall/CRC, 1991; 44074.
  • 18
    Pinhero JC, Bates DM. Mixed-effects Models in S and S-PLUS J. New York: Springer, 2000.
  • 19
    Kastrup J, Rorsgaard S, Parving H-H, Lassen NA. Impaired autoregulation of cerebral blood flow in long-term type I (insulin-dependent) diabetic patients with nephropathy and retinopathy. Clin Physiol 1986; 6: 54959.
  • 20
    Kastrup J, Norgaard T, Parving H-H, Henriksen O, Lassen NA. Impaired autoregulation of blood flow in subcutaneous tissue of long-term type 1 (insulin-dependent) diabetic patients with microangiopathy: an index of arteriolar dysfunction. Diabetologia 1985; 28: 7117.
  • 21
    Parving H-H, Kastrup J, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1984; 27: 54752.
  • 22
    Christensen PK, Hansen HP, Parving H-H. Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney Int 1997; 52: 136974.
  • 23
    Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 192530.
  • 24
    Sandeman DD, Shore AC, Tooke JE. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 1992; 327: 7604.
  • 25
    Imanishi M, Yoshioka K, Konishi Y, Okumura M, Okada N, Sato T et al. Glomerular hypertension as one cause of albuminuria in type II diabetic patients. Diabetologia 1999; 42: 9991005.
  • 26
    Huang ES, Meigs JB, Singer DE. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med 2001; 111: 63342.
  • 27
    Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci (Colch) 1996; 90: 18995.
  • 28
    Miller JA. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 1999; 10: 177885.
  • 29
    Allen TJ, Cooper ME, O'Brien RC, Bach LA, Jackson B, Jerums G. Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy. Diabetes 1990; 39: 118290.
  • 30
    Guyton AC. Medical Physiology, 8th edn. Philadelphia: W.B. Saunders Company, 1991.
  • 31
    Baughman KL. B-type natriuretic peptide – a window to the heart. N Engl J Med 2002; 347: 1589.
  • 32
    Andersen LJ, Norsk P, Johansen LB, Christensen P, Engstrom T, Bie P. Osmoregulatory control of renal sodium excretion after sodium loading in humans. Am J Physiol 1998; 275: R183342.
  • 33
    Andersen LJ, Jensen TU, Bestle MH, Bie P. Isotonic and hypertonic sodium loading in supine humans. Acta Physiol Scand 1999; 166: 2330.
  • 34
    Cooper ME. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001; 44: 195772.